Method for detecting of premenstrual syndrome
US5093265A · kind A · utility
6Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 1987 |
| Grant date | Mar 3, 1992 |
| Priority date | — |
| Expiry date | Dec 16, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Premenstrual syndrome (PMS) and other conditions may be diagnosed according to the invention by measuring the level of luteinizing hormone antibodies in the system of a woman subject. A low level of such antibodies as compared to levels measured for non-PMS women indicates that the patient suffers from PMS. A patient identified by this method is then treated as needed, such as by oral administration of progesterone, to alleviate the symptoms of the condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.